poisar

Stock

Scribe Therapeutics Inc. SCTX

$18.36+1.66%

Overview

SCTX market data

Price History

SCTX price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
Diluted earnings per share over the trailing twelve months.
Beta
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$17.31 – $25.49
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap .

Company News

3 captured
8-K filing — Scribe Therapeutics, Inc. (SCTX)SEC EDGAR · Jul 27, 2026, 9:08 PM
Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO security released for quotationBenzinga · Jul 24, 2026, 2:10 PM
Reported Earlier, Scribe Therapeutics Prices Upsized Initial Public Offering Of 8,580,000 Common Shares At $15.00 Per Share, Expects $128.7M In Gross ProceedsBenzinga · Jul 24, 2026, 7:11 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock